Illumina follows Agilent, Life Technologies, Affymetrix, Siemens, and Luminex in settling lawsuits alleging infringement of US Patent No 7,064,197.
Thermo Fisher Scientific subsidiary Life Technologies will pay Enzo $35 million for infringing on two patents pertaining to labeled nucleotides and nucleic acids.
Affymetrix will pay Enzo $10 million to settle litigation Enzo brought against the company over a method for nucleic acid analysis.
Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.
The deal comes after a California Superior Court found no fraudulent intent on the part of the company.
The companies had been involved in a years-long legal battle over whether Genmark's eSensor Respiratory Virus Panel infringed ViroNovative's human metapneumovirus IP.
The preliminary approval is the penultimate step to bringing to a close a class action lawsuit accusing Celera of making false and misleading statements about its finances.
A few more lawsuits related to Myriad Genetics' hereditary cancer testing patents are now put to bed.
The parties have decided to drop their claims and counterclaims against eachother ending a patent infringement lawsuit on BRCA testing.
The deal brings an end to a dispute going back to 2010 between the two firms.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.